Entry |
|
Name |
Vidupiprant (USAN/INN) |
Formula |
C28H27Cl2FN2O6S
|
Exact mass |
608.0951
|
Mol weight |
609.49
|
Structure |

|
Efficacy |
Antiasthmatic, Prostaglandin D2 receptor antagonist |
Comment |
Treatment of asthma
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Prostaglandin
PTGDR
D09990 Vidupiprant (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 40
1 C8x C 27.1068 -24.7317
2 C8y C 27.1068 -26.1331
3 C8x C 28.3204 -26.8338
4 C8y C 29.5340 -26.1331
5 C8y C 29.5340 -24.7317
6 C8x C 28.3204 -24.0310
7 O2a O 30.7664 -24.0200
8 C8y C 31.9727 -24.7164
9 C5a C 25.8932 -26.8338
10 N1b N 24.6965 -26.1427
11 O5a O 25.8931 -28.2349
12 C1d C 23.5080 -26.8289
13 C1a C 22.3156 -26.1402
14 C1a C 23.5078 -28.2349
15 C1a C 22.2944 -27.5295
16 N1b N 30.7664 -26.8448
17 S4a S 30.7664 -28.2461
18 C8y C 29.5457 -28.9510
19 C8x C 28.3357 -28.2525
20 C8x C 27.1221 -28.9532
21 C8y C 27.1221 -30.3546
22 C8x C 28.3321 -31.0531
23 C8y C 29.5457 -30.3524
24 C1y C 25.9048 -31.0576
25 C1x C 24.5034 -31.0576
26 C1x C 25.2041 -32.2712
27 O3c O 31.4670 -29.4597
28 O3c O 32.1677 -28.2461
29 C8x C 31.9731 -26.1327
30 C8y C 33.1870 -26.8331
31 C8y C 34.4004 -26.1320
32 C8x C 34.4000 -24.7156
33 C8y C 33.1861 -24.0153
34 X Cl 33.1859 -22.6298
35 X F 33.1874 -28.2350
36 C1b C 35.6099 -26.8298
37 C6a C 36.8028 -26.1403
38 O6a O 37.9936 -26.8273
39 O6a O 36.8024 -24.7319
40 X Cl 30.7627 -31.0551
BOND 43
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 5 6 1
6 1 6 2
7 5 7 1
8 7 8 1
9 2 9 1
10 9 10 1
11 9 11 2
12 10 12 1
13 12 13 1
14 12 14 1
15 12 15 1
16 4 16 1
17 16 17 1
18 17 18 1
19 18 19 1
20 19 20 2
21 20 21 1
22 21 22 2
23 22 23 1
24 18 23 2
25 21 24 1
26 24 25 1
27 25 26 1
28 26 24 1
29 17 27 2
30 17 28 2
31 8 29 1
32 29 30 2
33 30 31 1
34 31 32 2
35 32 33 1
36 8 33 2
37 33 34 1
38 30 35 1
39 31 36 1
40 36 37 1
41 37 38 1
42 37 39 2
43 23 40 1
|